These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37955745)

  • 41. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL; Patterson CC; Halahakoon CW;
    Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
    Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Wilson-Costello D; Walsh MC; Langer JC; Guillet R; Laptook AR; Stoll BJ; Shankaran S; Finer NN; Van Meurs KP; Engle WA; Das A;
    Pediatrics; 2009 Mar; 123(3):e430-7. PubMed ID: 19204058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of sex on the requirement for and outcomes following late postnatal corticosteroid treatment.
    Lee R; Kostina E; Dassios T; Greenough A
    Eur J Pediatr; 2023 Mar; 182(3):1417-1423. PubMed ID: 36692623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early low-dose hydrocortisone: is the neurodevelopment affected?
    Ofman G; Perez M; Farrow KN
    J Perinatol; 2018 Jun; 38(6):636-638. PubMed ID: 29467523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012-2019: a retrospective population cohort study.
    Yao S; Uthaya S; Gale C; Modi N; Battersby C;
    BMJ Open; 2022 Nov; 12(11):e063835. PubMed ID: 36396314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants.
    Haroon Parupia MF; Dhanireddy R
    J Perinatol; 2001 Jun; 21(4):242-7. PubMed ID: 11533841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
    Feldman DM; Carbone J; Belden L; Borgida AF; Herson V
    Am J Obstet Gynecol; 2007 Sep; 197(3):284.e1-4. PubMed ID: 17826422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2001; (1):CD001146. PubMed ID: 11279706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial.
    Crowther CA; Ashwood P; Andersen CC; Middleton PF; Tran T; Doyle LW; Robinson JS; Harding JE;
    Lancet Child Adolesc Health; 2019 Nov; 3(11):769-780. PubMed ID: 31523039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postnatal administration of systemic steroids increases severity of retinopathy in premature infants.
    Tao K
    Pediatr Neonatol; 2022 May; 63(3):220-226. PubMed ID: 34879992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between postnatal dexamethasone for treatment of bronchopulmonary dysplasia and brain volumes at adolescence in infants born very preterm.
    Cheong JL; Burnett AC; Lee KJ; Roberts G; Thompson DK; Wood SJ; Connelly A; Anderson PJ; Doyle LW;
    J Pediatr; 2014 Apr; 164(4):737-743.e1. PubMed ID: 24332820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001145. PubMed ID: 12535401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial.
    Hofer OJ; Harding JE; Tran T; Crowther CA
    PLoS One; 2022; 17(2):e0263927. PubMed ID: 35192656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.
    Stoll BJ; Hansen NI; Bell EF; Walsh MC; Carlo WA; Shankaran S; Laptook AR; Sánchez PJ; Van Meurs KP; Wyckoff M; Das A; Hale EC; Ball MB; Newman NS; Schibler K; Poindexter BB; Kennedy KA; Cotten CM; Watterberg KL; D'Angio CT; DeMauro SB; Truog WE; Devaskar U; Higgins RD;
    JAMA; 2015 Sep; 314(10):1039-51. PubMed ID: 26348753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronology and Determinants of Respiratory Function Changes Following Administration of Systemic Postnatal Corticosteroids in Extremely Preterm Infants.
    Dassios T; Kaltsogianni O; Hickey A; Bhat R; Greenough A
    J Pediatr; 2019 Dec; 215():17-23. PubMed ID: 31500862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perinatal Risk and Protective Factors in the Development of Diffuse White Matter Abnormality on Term-Equivalent Age Magnetic Resonance Imaging in Infants Born Very Preterm.
    Parikh NA; Sharma P; He L; Li H; Altaye M; Priyanka Illapani VS;
    J Pediatr; 2021 Jun; 233():58-65.e3. PubMed ID: 33259857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Perinatal glucocorticosteroid therapy: time for reconsideration].
    Groneck P
    Z Geburtshilfe Neonatol; 2001; 205(6):231-5. PubMed ID: 11745009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial.
    He Y; Zhang Y; Gao S; Wang X; He N; Zhang D; Dong W; Wieg C; Lei X
    Trials; 2020 Sep; 21(1):762. PubMed ID: 32883333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.